Association of intrauterine and early life factors with uterine leiomyomata in black women

Annals of Epidemiology

Volumn 22, Issue 12, 2012, Pages 847-854

  Wise, Lauren A ^a   Radin, Rose G ^a   Palmer, Julie R ^a   Rosenberg, Lynn ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

African Americans; Early life; Females; Intrauterine; Leiomyoma; Prospective studies; Soy formula

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; BIRTH WEIGHT; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; EUROPEAN AMERICAN; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; HYSTERECTOMY; INFANCY; LEIOMYOMA; MAJOR CLINICAL STUDY; PASSIVE SMOKING; PREMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOYBEAN MILK; TREATMENT INDICATION; ULTRASOUND; UTERINE LEIOMYOMATA; VALIDATION STUDY; WOMEN'S HEALTH;

ADULT; AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEIOMYOMA; MATERNAL AGE; MATERNAL EXPOSURE; MIDDLE AGED; ODDS RATIO; PREGNANCY; PREMENOPAUSE; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SOCIOECONOMIC FACTORS; TIME FACTORS; UNITED STATES; UTERINE NEOPLASMS; YOUNG ADULT;

EID: 84870248280     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2012.09.006     Document Type: Article

References (40)

1. Merrill R.M. Hysterectomy surveillance in the United States, 1997 through 2005. Med Sci Monit 2008, 14:CR24-CR31.
2. Rein M.S., Barbieri R.L., Friedman A.J. Progesterone: a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol 1995, 172:14-18.
3. Andersen J. Factors in fibroid growth. Baillieres Clin Obstet Gynaecol 1998, 12:225-243.
4. Marshall L.M., Spiegelman D., Barbieri R.L., Goldman M.B., Manson J.E., Colditz G.A., et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 1997, 90:967-973.
5. Baird D.D., Dunson D.B., Hill M.C., Cousins D., Schectman J.M. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003, 188:100-107.
6. Kjerulff K.H., Langenberg P., Seidman J.D., Stolley P.D., Guzinski G.M. Uterine leiomyomas: racial differences in severity, symptoms, and age at diagnosis. J Reprod Med 1996, 41:483-490.
7. Baird D.D. Invited commentary: uterine leiomyomata-we know so little but could learn so much. Am J Epidemiol 2004, 159:124-126.
8. Marshall L.M., Spiegelman D., Goldman M.B., Manson J.E., Colditz G.A., Barbieri R.L., et al. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril 1998, 70:432-439.
9. Wise L.A., Palmer J.R., Harlow B.L., Spiegelman D., Stewart E.A., Adams-Campbell L.L., et al. Reproductive factors, hormonal contraception and risk of uterine leiomyomata in African-American women: a prospective study. Am J Epidemiol 2004, 159:113-123.
10. Faerstein E., Szklo M., Rosenshein N. Risk factors for uterine leiomyoma: a practice-based case-control study. I. African-American heritage, reproductive history, body size, and smoking. Am J Epidemiol 2001, 153:1-10.
11. Templeman C., Marshall S.F., Clarke C.A., Henderson K.D., Largent J., Neuhausen S., et al. Risk factors for surgically removed fibroids in a large cohort of teachers. Fertil Steril 2009, 92:1436-1446.
12. Terry K.L., De Vivo I., Hankinson S.E., Missmer S.A. Reproductive characteristics and risk of uterine leiomyomata. Fertil Steril 2010, 94:2703-2707.
13. Baird D.D., Newbold R. Prenatal diethylstilbestrol (DES) exposure is associated with uterine leiomyoma development. Reprod Toxicol 2005, 20:81-84.
14. Missmer S.A., Hankinson S.E., Spiegelman D., Barbieri R.L., Michels K.B., Hunter D.J. In utero exposures and the incidence of endometriosis. Fertil Steril 2004, 82:1501-1508.
15. Wise L.A., Palmer J.R., Rowlings K., Kaufman R.H., Herbst A.L., Noller K.L., et al. Risk of benign gynecologic tumors in relation to prenatal diethylstilbestrol exposure. Obstet Gynecol 2005, 105:167-173.
16. D'Aloisio A.A., Baird D.D., DeRoo L.A., Sandler D.P. Association of intrauterine and early-life exposures with diagnosis of uterine leiomyomata by 35 years of age in the sister study. Environ Health Perspect 2010, 118:375-381.
17. D'Aloisio A.A., Baird D.D., DeRoo L.A., Sandler D.P. Early-Life Exposures and Early Onset Uterine Leiomyomata in Black Women in the Sister Study. Environ Health Perspect 2012, 120:406-412.
18. Smith L.L., Hines M. Language lateralization and handedness in women prenatally exposed to diethylstilbestrol (DES). Psychoneuroendocrinology 2000, 25:497-512.
19. Birkett P. Measures of laterality and theories of hemispheric processes. Neuropsychologia 1977, 15:693-696.
20. Bryden M.P. Evidence for sex-related differences in cerebral organization. Sex-related differences in cognitive functioning 1979, 121-143. Academic Press, New York.
21. Calnan M., Richardson K. Developmental correlates of handedness in a national sample of 11-year-olds. Ann Hum Biol 1976, 3:329-342.
22. Hines M., Gorski R. Hormonal influences on the development of neural asymmetries. The dual brain: hemispheric specialization in humans 1985, 75-96. Guilford, New York.
23. Nass R., Baker S., Speiser P., Virdis R., Balsamo A., Cacciari E., et al. Hormones and handedness: left-hand bias in female congenital adrenal hyperplasia patients. Neurology 1987, 37:711-715.
24. Baird D.D. Hypothesis: vitamin D protects against uterine fibroid development [Abstract]. Ann Epidemiol 2008, 18:710.
25. Blauer M., Rovio P.H., Ylikomi T., Heinonen P.K. Vitamin D inhibits myometrial and leiomyoma cell proliferation in vitro. Fertil Steril 2009, 91:1919-1925.
26. Sharan C., Halder S.K., Thota C., Jaleel T., Nair S., Al-Hendy A. Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase. Fertil Steril 2011, 95:247-253.
27. Rosenberg L., Adams-Campbell L.L., Palmer J.R. The Black Women's Health Study: a follow-up study for causes and preventions of illness. J Am Med Womens Assoc 1995, 50:56-58.
28. Schwartz S.M., Marshall L.M., Baird D.D. Epidemiologic contributions to understanding the etiology of uterine leiomyomata. Environ Health Perspect 2000, 108:821-827.
29. Loutradis D., Antsaklis A., Creatsas G., Hatzakis A., Kanakas N., Gougoulakis A., et al. The validity of gynecological ultrasonography. Gynecol Obstet Invest 1990, 29:47-50.
30. Dueholm M., Lundorf E., Hansen E.S., Ledertoug S., Olesen F. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol 2002, 186:409-415.
31. Myers E.R., Bastian L.A., Havrilesky L.J., Kulasingam S.L., Terplan M.S., Cline K.E., et al. Management of adnexal mass. Evid Rep Technol Assess (Full Rep) 2006, 1-145.
32. Wise L.A., Palmer J.R., Stewart E.A., Rosenberg L. Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study. Obstet Gynecol 2005, 105:563-568.
33. Breslow NE, Day NE. Statistical methods in cancer research, Vol. II. The design and analysis of cohort studies. In. Lyon, France: IARC Sci Publ; 1987. p. 1-406.
34. SAS/STAT® 9.2 user's guide 2008, SAS Institute Inc, SAS Institute, Cary (NC).
35. Zhou X.H., Eckert G.J., Tierney W.M. Multiple imputation in public health research. Stat Med 2001, 20:1541-1549.
36. Troisi R., Potischman N., Hoover R.N. Exploring the underlying hormonal mechanisms of prenatal risk factors for breast cancer: a review and commentary. Cancer Epidemiol Biomarkers Prev 2007, 16:1700-1712.
37. Bernstein L., Depue R.H., Ross R.K., Judd H.L., Pike M.C., Henderson B.E. Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. J Natl Cancer Inst 1986, 76:1035-1039.
38. Bernstein L., Lipworth L., Ross R.K., Trichopoulos D. Correlation of estrogen levels between successive pregnancies. Am J Epidemiol 1995, 142:625-628.
39. Dorgan J.F., Reichman M.E., Judd J.T., Brown C., Longcope C., Schatzkin A., et al. Relationships of age and reproductive characteristics with plasma estrogen and androgens in premenopausal women. Cancer Epidemiol Biomarkers Prev 1995, 4:381-386.
40. Rothman K.J., Greenland S., Lash T.L. Modern epidemiology 2008, Lippincott Williams & Wilkins, New York. 3rd ed.